PRAX

NASDAQ 已收盘

Praxis Precision Medicines

310.90 USD
▲+5.71+1.87%
盘后 313.89 +0.96%
2026-11-19
市值
$8.57B
市盈率
—
EPS
-12.76
股息率
—
52 周区间
160.11 – 392.70
成交量
634.64K
Beta
2.84
目标价
677.32
52W 低 160.1152W 高 392.70
价格走势

公司简介

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States. The company’s platforms include Cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and Solidus to discover and develop antisense oligonucleotide. It also develops ulixacaltamide, a small molecule inhibitor of T-type calcium channels that in N...